Clinical Trial Update: Target Controlled Infusion of Etomidate or Propofol for Anesthesia of Thoracoscopic Mitral Valve Replacement Surgery [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluates target-controlled infusion of etomidate or propofol for anesthesia during thoracoscopic mitral valve replacement surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Valve Disease
• Valvular Heart Disease

Drugs mentioned

• Etomidate (etomidate)
• PROPOFOL (Propofol)

Snippet

Sponsor: Xijing Hospital | Conditions: Delirium, Hemodynamic Instability | Phase 4 | Status: UNKNOWN